Results 41 to 50 of about 27,649 (256)
Cannabis; epidemiological, neurobiological and psychopathological issues: an update [PDF]
, 2017 This document is the Accepted Manuscript version of the following article: Maria Antonietta De Luca, Gaetano Di Chiara, Cristina Cadoni, Daniele Lecca, Laura Orsolini, Duccio Papanti, John Corkery, Fabrizio Schifano, 'Cannabis; Epidemiological ...
Cadoni, Cristina +7 more
core +3 more sources
Effectiveness of the synthetic cannabinoids seminar
Turkish Journal of Emergency Medicine, 2016 Objectives: Synthetic cannabinoid or “Bonzai” use is a public health issue as its use has increased in Turkey as well as all over the world. The aim of this study is to evaluate the effectiveness of the “Synthetic Cannabinoids Seminar” that was provided ...
Murat Seyit +3 more
doaj +1 more source
Cannabinoids and Cannabinoid Receptors: The Story so Far
iScience, 2020 Like most modern molecular biology and natural product chemistry, understanding cannabinoid pharmacology centers around molecular interactions, in this case, between the cannabinoids and their putative targets, the G-protein coupled receptors (GPCRs ...
Fred Shahbazi +3 more
doaj +1 more source
Correlation between blood and oral fluid psychoactive drug concentrations and cognitive impairment in driving under the influence of drugs [PDF]
, 2017 The effects of drugs on driving performance should be checked with drug concentration in the brain and at the same time with the evaluation of both the behavioural and neurophysiological effects. The best accessible indicator of this information is the
Busardò, Francesco Paolo +6 more
core +1 more source
Nanotherapies for Atherosclerosis: Targeting, Catalysis, and Energy Transduction
Advanced Healthcare Materials, EarlyView.Atherosclerosis management is hindered by poor drug targeting and plaque heterogeneity. Nanotechnology overcomes these barriers via three core strategies: (1) target‐engineered nanocarriers that achieve lesion‐specific precision via ligand modification, biomimetic camouflage, stimuli‐responsive release, and self‐propelling nanomotors; (2) catalytic ...
Yuqi Yang +4 more
wiley +1 more source
Synthetic cannabinoids impact on cognitive functions
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2023 Background Synthetic cannabinoids SC are now becoming progressively popular among young people worldwide; little is known about their negative effects.
Hanan Hany Elrassas +4 more
doaj +1 more source
Phytocannabinoids as novel therapeutic agents in CNS disorders [PDF]
, 2012 The Cannabis sativa herb contains over 100 phytocannabinoid (pCB) compounds and has been used for thousands of years for both recreational and medicinal purposes.
Hill, Andrew J. +3 more
core +1 more source
Plant‐Derived Melatonin Inhibits Bacterial Virulence via CpxA/R Two‐Component System
Advanced Science, EarlyView.Plant‐derived melatonin is sensed by CpxAE48/T51, which inhibits the phosphorylation cascade transmission from CpxAH240 to CpxRD52, resulting in the inhibition of DNA‐binding capacity of CpxR and subsequent T3SS genes expression in Pst DC3000. ABSTRACT In defending against pathogens, plants deploy diverse secondary metabolites and signaling molecules ...
Jin‐Wei Wei +7 more
wiley +1 more source
Substance use in the club scene of Rome : a pilot study [PDF]
, 2014 Date of Acceptance: 28/08/2014 Copyright © 2014 Alessandro Emiliano Vento et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium ...
Acciavatti, Tiziano +11 more
core +8 more sources
Clinical and Forensic Toxicological Aspects of Synthetic Cannabinoids: A Review and Update [PDF]
Asia Pacific Journal of Medical Toxicology, 2020 Background: Synthetic cannabinoids (SCs) are highly abused of New Psychoactive Substances (NPS). SCs has known under street names such as “Spice”, “herbal incense” and “K2”, act as endocannabinoids (CB) receptor full agonists and have unpredictable ...
Kambiz Soltaninejad
doaj +1 more source